| Autor: |
Tauber, Peter F., Wolf, Alfred S., Herting, Wigbert, Zaneveld, Lourens J.D. |
| Zdroj: |
Fertility and Sterility; December 1977, Vol. 28 Issue: 12 p1375-1377, 3p |
| Abstrakt: |
The intrauterine application of proteinase inhibitors, tranexamic acid and the pancreatic trypsin inhibitor (Trasylol), reduces or eliminates menorrhagia and intermenstrual bleeding (spotting) produced by an intrauterine device (IUD). A decrease in pain and vaginal (cervical) discharge is also frequently observed. A single application is usually sufficient, more than three never being required. The effect lasts for an average of three cycles. In addition to the clinical use of these agents for the treatment of uterine hemorrhage, the slow release of proteinase inhibitors from an IUD may well be useful in minimizing its side effects without interfering with its contraceptive activity. |
| Databáze: |
Supplemental Index |
| Externí odkaz: |
|
